| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 1.10e-19 | 46 | 75 | 12 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 5.31e-12 | 188 | 75 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 RPS2 COL27A1 COL5A3 OTOL1 COL25A1 | 2.48e-05 | 891 | 75 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase inhibitor activity | 4.90e-04 | 41 | 75 | 3 | GO:0030291 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 8.97e-04 | 12 | 75 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase inhibitor activity | 8.97e-04 | 12 | 75 | 2 | GO:0004861 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase regulator activity | 9.31e-04 | 51 | 75 | 3 | GO:0016538 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 | 9.81e-08 | 377 | 74 | 11 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 | 1.01e-07 | 378 | 74 | 11 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 | 1.03e-07 | 379 | 74 | 11 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 3.11e-07 | 76 | 74 | 6 | GO:0030199 | |
| GeneOntologyCellularComponent | collagen trimer | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COLEC11 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 4.40e-18 | 88 | 74 | 13 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 9.43e-09 | 21 | 74 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 COL25A1 | 2.36e-08 | 332 | 74 | 11 | GO:0005788 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 7.01e-08 | 12 | 74 | 4 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 7.01e-08 | 12 | 74 | 4 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type V trimer | 1.70e-07 | 4 | 74 | 3 | GO:0005588 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 3.28e-07 | 530 | 74 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 3.06e-06 | 656 | 74 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 3.15e-06 | 658 | 74 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 7.28e-05 | 122 | 74 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.23e-04 | 5 | 74 | 2 | GO:0005592 | |
| HumanPheno | Cigarette-paper scars | 1.38e-05 | 10 | 26 | 3 | HP:0001073 | |
| HumanPheno | Large fleshy ears | 3.26e-05 | 13 | 26 | 3 | HP:0002265 | |
| HumanPheno | Focal dystonia | 5.44e-05 | 139 | 26 | 6 | HP:0004373 | |
| HumanPheno | Subcutaneous spheroids | 7.49e-05 | 3 | 26 | 2 | HP:0025014 | |
| HumanPheno | Abnormal morphology of the radius | 7.60e-05 | 217 | 26 | 7 | HP:0002818 | |
| HumanPheno | Abnormal forearm bone morphology | 1.29e-04 | 236 | 26 | 7 | HP:0040072 | |
| HumanPheno | Abnormal forearm morphology | 1.40e-04 | 239 | 26 | 7 | HP:0002973 | |
| HumanPheno | Cervical insufficiency | 1.49e-04 | 4 | 26 | 2 | HP:0030009 | |
| HumanPheno | Piezogenic pedal papules | 1.49e-04 | 4 | 26 | 2 | HP:0025509 | |
| HumanPheno | Incisional hernia | 1.49e-04 | 4 | 26 | 2 | HP:0004872 | |
| HumanPheno | Telecanthus | 1.84e-04 | 173 | 26 | 6 | HP:0000506 | |
| HumanPheno | Hip dislocation | 2.54e-04 | 263 | 26 | 7 | HP:0002827 | |
| HumanPheno | Craniofacial dystonia | 3.31e-04 | 123 | 26 | 5 | HP:0012179 | |
| HumanPheno | Caudal appendage | 3.71e-04 | 6 | 26 | 2 | HP:0002825 | |
| HumanPheno | Prominent coccyx | 3.71e-04 | 6 | 26 | 2 | HP:0040016 | |
| HumanPheno | Abnormality of the elbow | 3.91e-04 | 282 | 26 | 7 | HP:0009811 | |
| HumanPheno | Esotropia | 5.00e-04 | 208 | 26 | 6 | HP:0000565 | |
| HumanPheno | Joint dislocation | 5.02e-04 | 390 | 26 | 8 | HP:0001373 | |
| HumanPheno | Pulp calcification | 5.18e-04 | 7 | 26 | 2 | HP:0003771 | |
| HumanPheno | Phalangeal dislocation | 5.18e-04 | 7 | 26 | 2 | HP:0006243 | |
| HumanPheno | Skull asymmetry | 5.18e-04 | 7 | 26 | 2 | HP:0002678 | |
| HumanPheno | Molluscoid pseudotumors | 5.18e-04 | 7 | 26 | 2 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 5.18e-04 | 7 | 26 | 2 | HP:0000139 | |
| HumanPheno | Spina bifida occulta | 5.61e-04 | 77 | 26 | 4 | HP:0003298 | |
| MousePheno | impaired lipolysis | 2.92e-05 | 14 | 62 | 3 | MP:0008033 | |
| Domain | Collagen | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COLEC11 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 1.39e-17 | 85 | 75 | 13 | IPR008160 |
| Domain | Collagen | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COLEC11 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 1.39e-17 | 85 | 75 | 13 | PF01391 |
| Domain | TSPN | 3.27e-10 | 23 | 75 | 6 | SM00210 | |
| Domain | Fib_collagen_C | 4.13e-10 | 11 | 75 | 5 | IPR000885 | |
| Domain | COLFI | 4.13e-10 | 11 | 75 | 5 | PF01410 | |
| Domain | NC1_FIB | 4.13e-10 | 11 | 75 | 5 | PS51461 | |
| Domain | Fib_collagen_C | 4.13e-10 | 11 | 75 | 5 | PD002078 | |
| Domain | COLFI | 4.13e-10 | 11 | 75 | 5 | SM00038 | |
| Domain | Laminin_G | 1.17e-07 | 58 | 75 | 6 | IPR001791 | |
| Domain | ConA-like_dom | 2.80e-05 | 219 | 75 | 7 | IPR013320 | |
| Domain | ZF_CR | 9.50e-05 | 4 | 75 | 2 | PS51188 | |
| Domain | DnaJ | 9.50e-05 | 4 | 75 | 2 | IPR012724 | |
| Domain | DnaJ_CXXCXGXG | 9.50e-05 | 4 | 75 | 2 | PF00684 | |
| Domain | - | 9.50e-05 | 4 | 75 | 2 | 2.10.230.10 | |
| Domain | HSP_DnaJ_Cys-rich_dom | 1.58e-04 | 5 | 75 | 2 | IPR001305 | |
| Domain | LAM_G_DOMAIN | 4.74e-04 | 38 | 75 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 5.52e-04 | 40 | 75 | 3 | PF02210 | |
| Domain | DnaJ_C | 5.62e-04 | 9 | 75 | 2 | IPR002939 | |
| Domain | DnaJ_C | 5.62e-04 | 9 | 75 | 2 | PF01556 | |
| Domain | HSP40/DnaJ_pept-bd | 5.62e-04 | 9 | 75 | 2 | IPR008971 | |
| Domain | - | 5.79e-04 | 95 | 75 | 4 | 2.60.120.200 | |
| Domain | LamG | 7.32e-04 | 44 | 75 | 3 | SM00282 | |
| Domain | ATPase_dyneun-rel_AAA | 1.40e-03 | 14 | 75 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.40e-03 | 14 | 75 | 2 | PF07728 | |
| Domain | DnaJ_domain_CS | 5.23e-03 | 27 | 75 | 2 | IPR018253 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 COL25A1 | 1.78e-17 | 44 | 59 | 11 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 COL25A1 | 2.77e-15 | 67 | 59 | 11 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL19A1 COL5A3 COL25A1 | 6.58e-14 | 41 | 59 | 9 | MM15538 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 COL25A1 | 8.34e-14 | 90 | 59 | 11 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL19A1 COL5A3 COL25A1 | 3.05e-12 | 61 | 59 | 9 | MM14637 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL19A1 COL5A3 COL25A1 | 4.80e-12 | 64 | 59 | 9 | M26953 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL19A1 COL5A3 COL25A1 | 2.39e-11 | 76 | 59 | 9 | MM14573 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.40e-11 | 53 | 59 | 8 | MM14566 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.43e-10 | 61 | 59 | 8 | M27103 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL19A1 COL5A3 COL25A1 | 5.98e-09 | 140 | 59 | 9 | M587 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.60e-08 | 20 | 59 | 5 | MM15061 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.25e-08 | 114 | 59 | 8 | MM14571 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 COL25A1 | 3.81e-08 | 300 | 59 | 11 | M610 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.70e-08 | 50 | 59 | 6 | MM14796 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.97e-08 | 85 | 59 | 7 | M16441 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.42e-07 | 30 | 59 | 5 | M27772 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.88e-07 | 38 | 59 | 5 | MM14969 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 7.21e-07 | 41 | 59 | 5 | M27778 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.22e-07 | 76 | 59 | 6 | MM14867 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 8.16e-07 | 42 | 59 | 5 | M7169 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL19A1 COL5A3 COL25A1 | 1.13e-06 | 258 | 59 | 9 | MM14572 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.83e-06 | 57 | 59 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.18e-06 | 58 | 59 | 5 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.31e-06 | 63 | 59 | 5 | M11187 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.94e-06 | 66 | 59 | 5 | M18 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 9.12e-06 | 32 | 59 | 4 | MM14924 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.59e-05 | 76 | 59 | 5 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.92e-05 | 79 | 59 | 5 | M27643 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.59e-05 | 84 | 59 | 5 | M7098 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.02e-05 | 43 | 59 | 4 | M39565 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 3.96e-05 | 46 | 59 | 4 | M198 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.32e-05 | 47 | 59 | 4 | MM14925 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.43e-05 | 19 | 59 | 3 | MM15512 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.06e-04 | 59 | 59 | 4 | M27218 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.77e-04 | 199 | 59 | 6 | M7253 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.90e-04 | 27 | 59 | 3 | M27217 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.56e-04 | 74 | 59 | 4 | M160 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.61e-04 | 30 | 59 | 3 | MM15517 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 3.57e-04 | 7 | 59 | 2 | MM14654 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 4.74e-04 | 8 | 59 | 2 | M27005 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 7.53e-04 | 261 | 59 | 6 | MM15676 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN | 7.58e-04 | 10 | 59 | 2 | M47879 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 9.24e-04 | 11 | 59 | 2 | MM14926 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 9.24e-04 | 11 | 59 | 2 | M47874 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.33e-03 | 52 | 59 | 3 | MM14949 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.74e-03 | 57 | 59 | 3 | M27251 | |
| Pathway | REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION | 2.25e-03 | 17 | 59 | 2 | M45017 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.31e-03 | 325 | 59 | 6 | M12868 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.76e-03 | 67 | 59 | 3 | MM15345 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 2.81e-03 | 19 | 59 | 2 | M27221 | |
| Pubmed | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL27A1 COL5A3 COL25A1 | 4.13e-12 | 167 | 77 | 10 | 22159717 | |
| Pubmed | COL23A1 COL5A1 COL5A2 COL6A1 COL18A1 ZBTB16 COL19A1 HGH1 COL5A3 PRKCG | 4.01e-11 | 210 | 77 | 10 | 16537572 | |
| Pubmed | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL25A1 | 6.08e-11 | 153 | 77 | 9 | 25037231 | |
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 4.62e-09 | 10 | 77 | 4 | 15345741 | |
| Pubmed | 5.48e-09 | 175 | 77 | 8 | 28071719 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 37158802 | ||
| Pubmed | Isolation of the alpha 3-chain of human type V collagen and characterization by partial sequencing. | 1.04e-08 | 3 | 77 | 3 | 1571108 | |
| Pubmed | Biosynthetic processing of the Pro-alpha1(V)Pro-alpha2(V)Pro-alpha3(V) procollagen heterotrimer. | 1.04e-08 | 3 | 77 | 3 | 15136578 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 1.56e-08 | 13 | 77 | 4 | 36335435 | |
| Pubmed | COL5A2 MYOF STRN3 MDN1 UBAP2L DNAJA2 SRP68 DNAJA1 TARS1 DYNC1H1 | 1.95e-08 | 399 | 77 | 10 | 37536630 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 10722718 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 5.78e-07 | 135 | 77 | 6 | 28675934 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 5.80e-07 | 8 | 77 | 3 | 20059976 | |
| Pubmed | 5.80e-07 | 8 | 77 | 3 | 15872058 | ||
| Pubmed | In vivo evidence for a bridging role of a collagen V subtype at the epidermis-dermis interface. | 5.80e-07 | 8 | 77 | 3 | 22437311 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 5.80e-07 | 8 | 77 | 3 | 33875569 | |
| Pubmed | 8.94e-07 | 233 | 77 | 7 | 37704626 | ||
| Pubmed | CACNA1A STRN3 MDN1 HNRNPUL2 UBAP2L DNAJA2 PURB PPP1R3F PRKCG TAF15 DNAJA1 DYNC1H1 | 1.33e-06 | 963 | 77 | 12 | 28671696 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | HNRNPUL2 LIN28B UBAP2L RPS2 DNAJA2 PURB SRP68 TAF15 SNRNP70 DNAJA1 | 2.51e-06 | 678 | 77 | 10 | 30209976 |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.56e-06 | 97 | 77 | 5 | 27559042 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 2.70e-06 | 98 | 77 | 5 | 21942715 | |
| Pubmed | CACNA1A STRN3 RAP1GAP HNRNPUL2 UBAP2L RPS2 DNAJA2 PURB PRICKLE2 SRP68 PRKCG TAF15 TARS1 DYNC1H1 | 2.77e-06 | 1431 | 77 | 14 | 37142655 | |
| Pubmed | COL4A4 TRIM33 COL5A2 KSR1 COL24A1 STRN3 MDN1 DNAJA2 PURB COL25A1 | 2.90e-06 | 689 | 77 | 10 | 36543142 | |
| Pubmed | Furin, a transcriptional target of NKX2-5, has an essential role in heart development and function. | 2.94e-06 | 13 | 77 | 3 | 30840660 | |
| Pubmed | MDN1 HNRNPUL2 UBAP2L RPS2 DNAJA2 TAF15 SNRNP70 DNAJA1 PREX1 DYNC1H1 | 4.54e-06 | 725 | 77 | 10 | 27025967 | |
| Pubmed | 4.73e-06 | 50 | 77 | 4 | 23658023 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22696272 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22208904 | ||
| Pubmed | Differential clinical significance of COL5A1 and COL5A2 in tongue squamous cell carcinoma. | 4.84e-06 | 2 | 77 | 2 | 30972812 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23587214 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26910848 | ||
| Pubmed | Exploring the genetic basis of 3MC syndrome: Findings in 12 further families. | 4.84e-06 | 2 | 77 | 2 | 26789649 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22132895 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28485813 | ||
| Pubmed | COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. | 4.84e-06 | 2 | 77 | 2 | 10777716 | |
| Pubmed | Structural abnormalities of the cornea and lid resulting from collagen V mutations. | 4.84e-06 | 2 | 77 | 2 | 16431952 | |
| Pubmed | Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. | 4.84e-06 | 2 | 77 | 2 | 20847697 | |
| Pubmed | Hsp40 proteins phase separate to chaperone the assembly and maintenance of membraneless organelles. | 4.84e-06 | 2 | 77 | 2 | 33229560 | |
| Pubmed | Diversity in the processing events at the N-terminus of type-V collagen. | 4.84e-06 | 2 | 77 | 2 | 8181482 | |
| Pubmed | Differential modulation of Ca(v)2.1 channels by calmodulin and Ca2+-binding protein 1. | 4.84e-06 | 2 | 77 | 2 | 11865310 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16280346 | ||
| Pubmed | Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome. | 4.84e-06 | 2 | 77 | 2 | 21258343 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20625483 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12145749 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31240246 | ||
| Pubmed | Arterial complications in classical Ehlers-Danlos syndrome: a case series. | 4.84e-06 | 2 | 77 | 2 | 32467296 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 6.17e-06 | 203 | 77 | 6 | 22083510 | |
| Pubmed | CACNA1A STRN3 HNRNPUL2 UBAP2L RPS2 DNAJA2 PURB PRICKLE2 PRKCG TACC2 SNRNP70 DNAJA1 | 7.42e-06 | 1139 | 77 | 12 | 36417873 | |
| Pubmed | HNRNPUL2 LIN28B UBAP2L RPS2 DNAJA2 PURB SRP68 TAF15 MRGBP DNAJA1 DYNC1H1 HEXIM1 | 8.39e-06 | 1153 | 77 | 12 | 29845934 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.12e-05 | 62 | 77 | 4 | 28344315 | |
| Pubmed | 1.16e-05 | 20 | 77 | 3 | 21888903 | ||
| Pubmed | 1.40e-05 | 494 | 77 | 8 | 26831064 | ||
| Pubmed | 1.42e-05 | 653 | 77 | 9 | 22586326 | ||
| Pubmed | Association of Polymorphisms of MASP1/3, COLEC10, and COLEC11 Genes with 3MC Syndrome. | 1.45e-05 | 3 | 77 | 2 | 32751929 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 20038637 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 20301422 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 14570872 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 27628582 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 6501291 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 23220946 | ||
| Pubmed | Wnt/Tcf1 pathway restricts embryonic stem cell cycle through activation of the Ink4/Arf locus. | 1.45e-05 | 3 | 77 | 2 | 28346462 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 15908193 | ||
| Pubmed | Tumour suppressor TRIM33 targets nuclear β-catenin degradation. | 1.45e-05 | 3 | 77 | 2 | 25639486 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 11741999 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 7346227 | ||
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 1.45e-05 | 3 | 77 | 2 | 9582436 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 20956340 | ||
| Pubmed | 1.82e-05 | 145 | 77 | 5 | 23349634 | ||
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 2.30e-05 | 256 | 77 | 6 | 35777956 | |
| Pubmed | TRIM33 COL18A1 MYOF STRN3 CEBPB MDN1 PURB SRP68 TAF15 ZBTB7B PREX1 EDRF1 HEXIM1 | 2.33e-05 | 1497 | 77 | 13 | 31527615 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.40e-05 | 258 | 77 | 6 | 37794589 | |
| Pubmed | Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. | 2.51e-05 | 155 | 77 | 5 | 22673621 | |
| Pubmed | HNRNPUL2 LIN28B RPS2 DNAJA2 PURB TAF15 SNRNP70 DNAJA1 HEXIM1 | 2.83e-05 | 713 | 77 | 9 | 29802200 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 33147208 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 12874293 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 15207008 | ||
| Pubmed | Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1. | 2.89e-05 | 4 | 77 | 2 | 22085931 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 25987251 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 18684711 | ||
| Pubmed | Interactions between collagen gene variants and risk of anterior cruciate ligament rupture. | 2.89e-05 | 4 | 77 | 2 | 25073002 | |
| Pubmed | Human DnaJ homologs dj2 and dj3, and bag-1 are positive cochaperones of hsc70. | 2.89e-05 | 4 | 77 | 2 | 10816573 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 24174618 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 32041782 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 29654190 | ||
| Pubmed | 3.66e-05 | 29 | 77 | 3 | 22613833 | ||
| Pubmed | RNA binding proteins co-localize with small tau inclusions in tauopathy. | 4.02e-05 | 283 | 77 | 6 | 30068389 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 4.60e-05 | 759 | 77 | 9 | 35915203 | |
| Pubmed | Multi-transcription factor reporter mice delineate early precursors to the ILC and LTi lineages. | 4.82e-05 | 5 | 77 | 2 | 33104170 | |
| Pubmed | Physical mapping of mouse collagen genes on chromosome 10 by high-resolution FISH. | 4.82e-05 | 5 | 77 | 2 | 11331940 | |
| Pubmed | The transcription factor TCF-1 enforces commitment to the innate lymphoid cell lineage. | 4.82e-05 | 5 | 77 | 2 | 31358996 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 16728390 | ||
| Pubmed | Hsp40 chaperones promote degradation of the HERG potassium channel. | 4.82e-05 | 5 | 77 | 2 | 19940115 | |
| Pubmed | 4.94e-05 | 32 | 77 | 3 | 23154389 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 5.00e-05 | 179 | 77 | 5 | 36261009 | |
| Pubmed | Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly. | 5.58e-05 | 93 | 77 | 4 | 38245532 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 6.01e-05 | 607 | 77 | 8 | 39147351 | |
| Pubmed | Affinity purification strategies for proteomic analysis of transcription factor complexes. | 6.58e-05 | 97 | 77 | 4 | 23937658 | |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 22988097 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 27983982 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 21467034 | ||
| Interaction | LARP1 interactions | TRIM33 KSR1 CEBPB HNRNPUL2 LIN28B RPS2 SRP68 TACC2 TAF15 SNRNP70 ZBTB7B DYNC1H1 | 1.61e-07 | 465 | 76 | 12 | int:LARP1 |
| Interaction | LAIR2 interactions | 1.12e-06 | 49 | 76 | 5 | int:LAIR2 | |
| Interaction | DNAJA2 interactions | KLHL11 KSR1 STRN3 CEBPB DNAJA2 SNRNP70 ZBTB7B DNAJA1 TARS1 EDRF1 C2CD5 | 5.67e-06 | 542 | 76 | 11 | int:DNAJA2 |
| Interaction | MOB3C interactions | 9.10e-06 | 364 | 76 | 9 | int:MOB3C | |
| Interaction | C1QC interactions | 1.87e-05 | 42 | 76 | 4 | int:C1QC | |
| Interaction | COL8A2 interactions | 1.87e-05 | 42 | 76 | 4 | int:COL8A2 | |
| Interaction | RFC4 interactions | 2.37e-05 | 227 | 76 | 7 | int:RFC4 | |
| Interaction | C1QTNF1 interactions | 2.95e-05 | 47 | 76 | 4 | int:C1QTNF1 | |
| Interaction | H1-4 interactions | COL23A1 COL5A1 COL5A2 CEBPB RPS2 PURB SRP68 TACC2 ZBTB7B TARS1 HEXIM1 | 3.35e-05 | 656 | 76 | 11 | int:H1-4 |
| Interaction | BZW1 interactions | 6.67e-05 | 183 | 76 | 6 | int:BZW1 | |
| Interaction | ILF2 interactions | MYOF CEBPB HNRNPUL2 RPS2 SRP68 TAF15 SNRNP70 ZBTB7B DYNC1H1 HEXIM1 | 7.20e-05 | 590 | 76 | 10 | int:ILF2 |
| Interaction | HNRNPM interactions | COL4A4 TRIM33 USP13 CEBPB RPS2 OTOL1 TAF15 MRGBP SNRNP70 ZBTB7B HEXIM1 | 8.04e-05 | 723 | 76 | 11 | int:HNRNPM |
| Interaction | SMARCC1 interactions | 9.84e-05 | 384 | 76 | 8 | int:SMARCC1 | |
| Interaction | FGD4 interactions | 1.00e-04 | 64 | 76 | 4 | int:FGD4 | |
| Interaction | PLOD1 interactions | 1.16e-04 | 292 | 76 | 7 | int:PLOD1 | |
| Interaction | MTDH interactions | COL4A4 COL6A1 ZBTB16 CEBPB PURB TBC1D2B SRP68 SNRNP70 ZBTB7B | 1.16e-04 | 505 | 76 | 9 | int:MTDH |
| Interaction | MMP9 interactions | 1.20e-04 | 67 | 76 | 4 | int:MMP9 | |
| Interaction | FUS interactions | COL18A1 HNRNPUL2 UBAP2L PURB TAF15 SNRNP70 ZBTB7B CCNQ TARS1 DYNC1H1 HEXIM1 | 1.21e-04 | 757 | 76 | 11 | int:FUS |
| Interaction | FAU interactions | 1.38e-04 | 209 | 76 | 6 | int:FAU | |
| Interaction | LARP4 interactions | 1.42e-04 | 210 | 76 | 6 | int:LARP4 | |
| Interaction | ITGB2 interactions | 1.42e-04 | 132 | 76 | 5 | int:ITGB2 | |
| Interaction | TOP2A interactions | 1.45e-04 | 520 | 76 | 9 | int:TOP2A | |
| Interaction | H1-2 interactions | COL5A1 CEBPB LIN28B RPS2 PURB AEBP2 SRP68 SNRNP70 ZBTB7B HEXIM1 | 1.94e-04 | 666 | 76 | 10 | int:H1-2 |
| Interaction | BGN interactions | 1.94e-04 | 30 | 76 | 3 | int:BGN | |
| Interaction | HSPA4 interactions | TRIM33 COL6A1 USP13 CEBPB GOLGA6L2 DNAJA2 PRKCG MRGBP DNAJA1 HEXIM1 | 1.96e-04 | 667 | 76 | 10 | int:HSPA4 |
| Interaction | DNAJC7 interactions | 1.97e-04 | 425 | 76 | 8 | int:DNAJC7 | |
| Interaction | TGM2 interactions | 2.61e-04 | 235 | 76 | 6 | int:TGM2 | |
| Interaction | PHB1 interactions | COL6A1 CEBPB MDN1 HNRNPUL2 UBAP2L RPS2 DNAJA2 TAF15 SNRNP70 DNAJA1 PREX1 DYNC1H1 HEXIM1 | 2.68e-04 | 1123 | 76 | 13 | int:PHB1 |
| Interaction | SMAD3 interactions | 2.77e-04 | 447 | 76 | 8 | int:SMAD3 | |
| Interaction | BAG6 interactions | 2.90e-04 | 450 | 76 | 8 | int:BAG6 | |
| Interaction | PURB interactions | 3.09e-04 | 156 | 76 | 5 | int:PURB | |
| Interaction | CCT8L2 interactions | 3.19e-04 | 157 | 76 | 5 | int:CCT8L2 | |
| Interaction | HTATSF1 interactions | 3.19e-04 | 157 | 76 | 5 | int:HTATSF1 | |
| Interaction | MMP2 interactions | 3.28e-04 | 87 | 76 | 4 | int:MMP2 | |
| Interaction | EIF2S2 interactions | 3.41e-04 | 247 | 76 | 6 | int:EIF2S2 | |
| Interaction | U2SURP interactions | 3.45e-04 | 349 | 76 | 7 | int:U2SURP | |
| Interaction | DDX21 interactions | TRIM33 CEBPB HNRNPUL2 LIN28B RPS2 SRP68 TAF15 SNRNP70 ZBTB7B HEXIM1 | 3.54e-04 | 718 | 76 | 10 | int:DDX21 |
| Interaction | HNRNPUL1 interactions | 3.57e-04 | 351 | 76 | 7 | int:HNRNPUL1 | |
| Interaction | SPOPL interactions | 3.65e-04 | 37 | 76 | 3 | int:SPOPL | |
| Interaction | DHX57 interactions | 3.79e-04 | 252 | 76 | 6 | int:DHX57 | |
| Interaction | EIF3A interactions | 3.82e-04 | 355 | 76 | 7 | int:EIF3A | |
| Interaction | RNF2 interactions | HNRNPUL2 RPS2 DNAJA2 PURB SRP68 TAF15 MRGBP SNRNP70 ZBTB7B TARS1 DYNC1H1 | 3.86e-04 | 866 | 76 | 11 | int:RNF2 |
| Interaction | PRMT5 interactions | 3.93e-04 | 471 | 76 | 8 | int:PRMT5 | |
| GeneFamily | Collagens | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 COL25A1 | 1.67e-19 | 46 | 48 | 11 | 490 |
| Coexpression | NABA_COLLAGENS | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 COL25A1 | 3.05e-19 | 43 | 76 | 11 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 COL25A1 | 4.06e-19 | 44 | 76 | 11 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 1.93e-11 | 270 | 76 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 2.39e-11 | 275 | 76 | 12 | M5884 |
| Coexpression | NABA_MATRISOME | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COLEC11 MASP1 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 1.05e-06 | 1008 | 76 | 14 | MM17056 |
| Coexpression | NABA_MATRISOME | COL23A1 COL4A4 COL5A1 COL5A2 COL6A1 COL18A1 COL24A1 COLEC11 MASP1 COL19A1 COL27A1 COL5A3 OTOL1 COL25A1 | 1.30e-06 | 1026 | 76 | 14 | M5889 |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN | 1.84e-06 | 199 | 76 | 7 | M4673 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.16e-05 | 194 | 76 | 6 | M39122 | |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN | 2.36e-05 | 197 | 76 | 6 | M5760 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | COL5A2 DGLUCY MTMR12 TAPT1 TIMM23B PRICKLE2 TACC2 PREX1 HEXIM1 | 4.74e-05 | 583 | 76 | 9 | M17454 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 8.11e-05 | 29 | 76 | 3 | MM17055 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 9.10e-05 | 493 | 76 | 8 | M19391 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 9.10e-05 | 493 | 76 | 8 | M1951 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 1.06e-04 | 504 | 76 | 8 | MM830 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.07e-04 | 505 | 76 | 8 | M39167 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.20e-04 | 33 | 76 | 3 | M9167 | |
| Coexpression | UEDA_PERIFERAL_CLOCK | 1.42e-04 | 171 | 76 | 5 | M12498 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.43e-04 | 35 | 76 | 3 | M11788 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL5A1 COL5A2 COL6A1 COL18A1 MYOF CEBPB C11orf96 COL5A3 TARS1 | 1.54e-04 | 681 | 76 | 9 | M39175 |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.56e-04 | 36 | 76 | 3 | MM1212 | |
| Coexpression | UEDA_PERIFERAL_CLOCK | 1.66e-04 | 177 | 76 | 5 | MM1145 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.14e-04 | 40 | 76 | 3 | M5887 | |
| Coexpression | GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP | 2.86e-04 | 199 | 76 | 5 | M3060 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN | 2.86e-04 | 199 | 76 | 5 | M4331 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 2.93e-04 | 200 | 76 | 5 | M6243 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN | 2.93e-04 | 200 | 76 | 5 | M8278 | |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TEFF_DN | 2.93e-04 | 200 | 76 | 5 | M3424 | |
| Coexpression | GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP | 2.93e-04 | 200 | 76 | 5 | M6944 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | 3.06e-04 | 589 | 76 | 8 | M45662 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.01e-05 | 103 | 74 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | ROBO4 COL5A2 COL6A1 COL24A1 MYOF DGLUCY MASP1 RAP1GAP PRICKLE2 EFCC1 FHDC1 COL25A1 | 4.79e-05 | 878 | 74 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.86e-05 | 204 | 74 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.52e-05 | 207 | 74 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | COL6A1 COL24A1 MYOF DGLUCY MASP1 RAP1GAP PRICKLE2 EFCC1 COL25A1 | 9.06e-05 | 529 | 74 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | CACNA1A ROBO4 COL6A1 COL24A1 MYOF DGLUCY RAP1GAP LIN28B CARMIL3 PRICKLE2 EFCC1 COL25A1 | 1.20e-04 | 967 | 74 | 12 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL5A1 COL5A2 COL6A1 COL18A1 COLEC11 COL27A1 C11orf96 COL5A3 COL25A1 | 7.03e-11 | 200 | 77 | 9 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL23A1 COL5A1 COL24A1 COL27A1 C11orf96 PRICKLE2 EFCC1 TACC2 | 1.02e-09 | 182 | 77 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-09 | 197 | 77 | 8 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-09 | 197 | 77 | 8 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-09 | 199 | 77 | 8 | a697b3f0760e66bad8ea8d83cf6fea5934692c56 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-09 | 200 | 77 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-08 | 169 | 77 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.60e-08 | 187 | 77 | 7 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-08 | 188 | 77 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.32e-08 | 192 | 77 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.47e-08 | 193 | 77 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.97e-08 | 196 | 77 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-08 | 198 | 77 | 7 | 229588189825b1080181db9515185677b742c668 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-08 | 198 | 77 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-08 | 198 | 77 | 7 | 38b37daf41d84e5bf913eb3f72963418b7c0aac6 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-08 | 198 | 77 | 7 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.33e-08 | 198 | 77 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-07 | 140 | 77 | 6 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 5.23e-07 | 171 | 77 | 6 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.20e-07 | 176 | 77 | 6 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.40e-07 | 177 | 77 | 6 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.40e-07 | 177 | 77 | 6 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.40e-07 | 177 | 77 | 6 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.84e-07 | 179 | 77 | 6 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-07 | 180 | 77 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.30e-07 | 181 | 77 | 6 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.78e-07 | 183 | 77 | 6 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.78e-07 | 183 | 77 | 6 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.78e-07 | 183 | 77 | 6 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 8.03e-07 | 184 | 77 | 6 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.29e-07 | 185 | 77 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 8.29e-07 | 185 | 77 | 6 | a62ebaff92f2ed27b27b32c27c89cfbe2cb35116 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.56e-07 | 186 | 77 | 6 | 827f2f2ddde315d1e5970dd56f906c555ec699af | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-07 | 186 | 77 | 6 | d3509a579871ba6a8c4edd6137b28f271c9dbe70 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-07 | 186 | 77 | 6 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.83e-07 | 187 | 77 | 6 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 9.11e-07 | 188 | 77 | 6 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 9.11e-07 | 188 | 77 | 6 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.39e-07 | 189 | 77 | 6 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 9.39e-07 | 189 | 77 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-07 | 189 | 77 | 6 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-07 | 189 | 77 | 6 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 9.39e-07 | 189 | 77 | 6 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-07 | 189 | 77 | 6 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.69e-07 | 190 | 77 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.99e-07 | 191 | 77 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-07 | 191 | 77 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.99e-07 | 191 | 77 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.03e-06 | 192 | 77 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-06 | 193 | 77 | 6 | 3ea6b103e35bbb276e95301999618558fa3e38b1 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 193 | 77 | 6 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 193 | 77 | 6 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-06 | 193 | 77 | 6 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-06 | 193 | 77 | 6 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 193 | 77 | 6 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | mild_COVID-19-MAIT|World / disease group, cell group and cell class (v2) | 1.13e-06 | 195 | 77 | 6 | 74f0f709d9b3eed5d7e02a51884f02cc281782f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.20e-06 | 197 | 77 | 6 | 4a04da876a1482604452ae53c124ae68eda0bd5e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 197 | 77 | 6 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-06 | 198 | 77 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-06 | 198 | 77 | 6 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.23e-06 | 198 | 77 | 6 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-06 | 198 | 77 | 6 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.27e-06 | 199 | 77 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-06 | 199 | 77 | 6 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.27e-06 | 199 | 77 | 6 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | distal-mesenchymal-Myofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-06 | 199 | 77 | 6 | 79917b5225cb45b4a0ea937f79f1752346e4346e | |
| ToppCell | distal-mesenchymal-Pericyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-06 | 199 | 77 | 6 | e72ac7a00405cde06293d7adac7dc40eb0cf87ba | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.31e-06 | 200 | 77 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | distal-mesenchymal-Pericyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-06 | 200 | 77 | 6 | fe31287cfb51d45643bdedbaa5efc03ed87263c6 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 200 | 77 | 6 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-06 | 200 | 77 | 6 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-06 | 200 | 77 | 6 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 200 | 77 | 6 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | distal-1-mesenchymal-Pericyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-06 | 200 | 77 | 6 | ff205afda57b9267016f0c937445da1b0266af9b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 200 | 77 | 6 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.31e-06 | 200 | 77 | 6 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 200 | 77 | 6 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 200 | 77 | 6 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD8_Naive|Int-URO / Disease, Lineage and Cell Type | 6.69e-06 | 152 | 77 | 5 | 52d6f9cf1f4637c922f582705d625b4cbe3dc0c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.36e-06 | 155 | 77 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.83e-06 | 157 | 77 | 5 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.96e-06 | 165 | 77 | 5 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.96e-06 | 165 | 77 | 5 | 15fd9d21dccfa80656a6fa3b72286a6a9252d403 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 167 | 77 | 5 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 167 | 77 | 5 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 167 | 77 | 5 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.09e-05 | 168 | 77 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 169 | 77 | 5 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.12e-05 | 169 | 77 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 169 | 77 | 5 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-05 | 171 | 77 | 5 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.22e-05 | 172 | 77 | 5 | 58eaadf12366701103a0d1f133462c9495fedc30 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.22e-05 | 172 | 77 | 5 | 4483073469001770015526303772fd54906c5d68 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 174 | 77 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.32e-05 | 175 | 77 | 5 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-05 | 178 | 77 | 5 | 674ee5095b98929c29e4f6bd56029a336cc4a38c | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.48e-05 | 179 | 77 | 5 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.48e-05 | 179 | 77 | 5 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 180 | 77 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-05 | 180 | 77 | 5 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 | |
| Computational | Neighborhood of CDH11 | 1.38e-04 | 25 | 44 | 3 | GNF2_CDH11 | |
| Drug | GK-101 | 2.69e-11 | 36 | 76 | 7 | CID000161853 | |
| Drug | AC1LAKND | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 3.09e-11 | 62 | 76 | 8 | CID000470146 |
| Drug | BAPN | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 9.48e-11 | 71 | 76 | 8 | CID000001647 |
| Drug | Madecassol | 1.68e-10 | 46 | 76 | 7 | CID000108062 | |
| Drug | d-indobufen | 3.10e-10 | 50 | 76 | 7 | CID000044562 | |
| Drug | ridogrel | 4.13e-10 | 52 | 76 | 7 | CID005362391 | |
| Drug | halofuginone lactate | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 4.13e-10 | 85 | 76 | 8 | CID000062891 |
| Drug | NSC49633 | 4.74e-10 | 53 | 76 | 7 | CID000023340 | |
| Drug | 4-hydroxyproline | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 7.18e-10 | 91 | 76 | 8 | CID000000825 |
| Drug | PCR 4099 | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 UBAP2L COL27A1 COL25A1 | 9.14e-10 | 139 | 76 | 9 | CID000002806 |
| Drug | ticlopidine | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 1.95e-09 | 103 | 76 | 8 | CID000005472 |
| Drug | hydroxylysine | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 3.06e-09 | 109 | 76 | 8 | CID000001029 |
| Drug | malotilate | 3.90e-09 | 71 | 76 | 7 | CID000004006 | |
| Drug | Tranilast sodium | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 4.69e-09 | 115 | 76 | 8 | CID000005527 |
| Drug | AC1NMZ1B | 5.76e-09 | 75 | 76 | 7 | CID005034185 | |
| Drug | strontium ranelate | 6.94e-09 | 77 | 76 | 7 | CID006918182 | |
| Drug | Selara | 9.08e-09 | 125 | 76 | 8 | CID000150310 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL27A1 PRKCG COL25A1 LTB4R2 | 1.36e-08 | 189 | 76 | 9 | CID000001413 |
| Drug | DMSe | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL27A1 COL5A3 COL25A1 | 1.40e-08 | 132 | 76 | 8 | CID000020796 |
| Drug | pirfenidone | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 1.98e-08 | 138 | 76 | 8 | CID000040632 |
| Drug | DL-penicillamine | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 2.09e-08 | 139 | 76 | 8 | CID000004727 |
| Drug | silibinin | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 PRKCG COL25A1 CCNQ | 3.72e-08 | 285 | 76 | 10 | CID000005213 |
| Drug | AC1Q6PCP | BSND COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 7.42e-08 | 230 | 76 | 9 | CID000005267 |
| Drug | AC1L1C2F | 8.42e-08 | 110 | 76 | 7 | CID000001711 | |
| Drug | PPACK | 1.01e-07 | 113 | 76 | 7 | CID003036757 | |
| Drug | khellin | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 1.05e-07 | 171 | 76 | 8 | CID000003828 |
| Drug | AC1L9732 | 1.08e-07 | 114 | 76 | 7 | CID000439300 | |
| Drug | AC1L18QD | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 PRKCG COL25A1 LTB4R2 | 1.27e-07 | 325 | 76 | 10 | CID000000213 |
| Drug | AC1L1DD6 | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 1.49e-07 | 179 | 76 | 8 | CID000002299 |
| Drug | L-3,4-dehydroproline | 1.61e-07 | 73 | 76 | 6 | CID000094284 | |
| Drug | foscarnet | COL23A1 CACNA1A COL5A1 COL6A1 COL18A1 COL24A1 COL27A1 COL25A1 | 2.36e-07 | 190 | 76 | 8 | CID000003414 |
| Drug | AC1L1KMJ | COL23A1 CABP1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 PRKCG COL25A1 SLC4A5 | 5.01e-07 | 476 | 76 | 11 | CID000030956 |
| Drug | candesartan cilexetil | 5.56e-07 | 145 | 76 | 7 | CID000002540 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.17e-06 | 162 | 76 | 7 | CID000072363 | |
| Drug | hyaluronan | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 2.73e-06 | 263 | 76 | 8 | CID000024759 |
| Drug | losartan | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 PRKCG COL25A1 | 4.66e-06 | 378 | 76 | 9 | CID000003961 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 ZBTB16 COL27A1 COL25A1 | 1.00e-05 | 314 | 76 | 8 | CID000447989 |
| Drug | prostacyclin sodium salt | 2.03e-05 | 250 | 76 | 7 | CID000000159 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 3.41e-05 | 183 | 76 | 6 | 6944_UP | |
| Drug | colchine | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 4.15e-05 | 383 | 76 | 8 | CID000002833 |
| Drug | GW8510; Up 200; 10uM; MCF7; HT_HG-U133A | 4.45e-05 | 192 | 76 | 6 | 7062_UP | |
| Drug | 5114445; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.58e-05 | 193 | 76 | 6 | 901_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 6466_DN | |
| Drug | nitrendipine; Up 200; 10uM; MCF7; HG-U133A | 5.29e-05 | 198 | 76 | 6 | 336_UP | |
| Drug | FK-506; Down 200; 1uM; MCF7; HG-U133A | 5.44e-05 | 199 | 76 | 6 | 284_DN | |
| Drug | chondroitin sulfate | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 | 7.04e-05 | 413 | 76 | 8 | CID000024766 |
| Drug | CD 437 | 1.02e-04 | 223 | 76 | 6 | ctd:C099555 | |
| Drug | aspirin | COL23A1 COL5A1 COL6A1 COL18A1 COL24A1 COL19A1 COL27A1 COL25A1 LTB4R2 | 1.06e-04 | 563 | 76 | 9 | CID000002244 |
| Drug | Y-27632 | 1.16e-04 | 444 | 76 | 8 | CID000005711 | |
| Drug | tamibarotene | 1.63e-04 | 596 | 76 | 9 | ctd:C061133 | |
| Disease | Carnevale syndrome | 6.55e-06 | 2 | 76 | 2 | C0796279 | |
| Disease | Oculopalatoskeletal syndrome | 6.55e-06 | 2 | 76 | 2 | C0796059 | |
| Disease | Ehlers-Danlos syndrome type 1 | 6.55e-06 | 2 | 76 | 2 | C0268335 | |
| Disease | Ehlers-Danlos syndrome type 2 | 6.55e-06 | 2 | 76 | 2 | C0268336 | |
| Disease | Ehlers-Danlos syndrome classic type | 6.55e-06 | 2 | 76 | 2 | C4225429 | |
| Disease | Ehlers-Danlos syndrome, classic type | 6.55e-06 | 2 | 76 | 2 | cv:C4225429 | |
| Disease | Malpuech facial clefting syndrome | 1.96e-05 | 3 | 76 | 2 | C0796032 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 1.96e-05 | 3 | 76 | 2 | C4552122 | |
| Disease | Craniofacial ulnar renal syndrome | 1.96e-05 | 3 | 76 | 2 | C4303860 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 1.96e-05 | 3 | 76 | 2 | C0220679 | |
| Disease | Ehlers-Danlos syndrome classic type 1 (implicated_via_orthology) | 1.96e-05 | 3 | 76 | 2 | DOID:14720 (implicated_via_orthology) | |
| Disease | Incontinentia Pigmenti Achromians | 6.51e-05 | 5 | 76 | 2 | C0022283 | |
| Disease | Pigmentation Disorders | 6.51e-05 | 5 | 76 | 2 | C0549567 | |
| Disease | Schamberg Disease | 6.51e-05 | 5 | 76 | 2 | C0036305 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 9.75e-05 | 6 | 76 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.36e-04 | 7 | 76 | 2 | C1846545 | |
| Disease | acute promyelocytic leukemia (is_implicated_in) | 1.36e-04 | 7 | 76 | 2 | DOID:0060318 (is_implicated_in) | |
| Disease | Bleeding tendency | 1.36e-04 | 7 | 76 | 2 | C1458140 | |
| Disease | Ehlers-Danlos syndrome | 1.81e-04 | 8 | 76 | 2 | cv:C0013720 | |
| Disease | cortical surface area change measurement | 1.81e-04 | 8 | 76 | 2 | EFO_0021503 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.33e-04 | 9 | 76 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.51e-04 | 53 | 76 | 3 | C4707243 | |
| Disease | cystic fibrosis associated meconium ileus | 5.84e-04 | 14 | 76 | 2 | EFO_0004608 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 6.73e-04 | 15 | 76 | 2 | EFO_0008223 | |
| Disease | Blood Coagulation Disorders | 7.67e-04 | 16 | 76 | 2 | C0005779 | |
| Disease | intraocular pressure measurement | 2.02e-03 | 509 | 76 | 6 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEADGPGSGGGEEAM | 2416 | O00555 | |
| GGGVGGGEAETMSEP | 71 | Q6ZN18 | |
| DMGDPGFGGEKGSSP | 726 | P53420 | |
| GAKGAIGPPGDEGEM | 951 | P53420 | |
| MEAPEGGGGGPAARG | 1 | Q8N1B3 | |
| AIKEGGAGGGFGSPM | 71 | P31689 | |
| MGGGDGAAFKRPGDG | 1 | Q9NZU7 | |
| TGAEAGMEGAGGDPY | 6 | Q9HA90 | |
| DKDGRGPMTGSSGGD | 191 | Q92804 | |
| GDPEEGGEGDGSMSS | 796 | Q9C0D6 | |
| GGEGDGSMSSGVGEM | 801 | Q9C0D6 | |
| MELPETGSEGGDGGG | 201 | Q96EL1 | |
| EGGGIGEGEGMKDVS | 4676 | Q9NU22 | |
| MLGKGVVGGGGGTKA | 1 | Q9C0I1 | |
| MGDAKEAGAEGPPAG | 1 | Q3B7T1 | |
| GAAMEGTGGELGGQG | 36 | Q5U4P2 | |
| MAEGGASKGGGEEPG | 1 | Q6ZN17 | |
| KMGTEGSEPGEGGPA | 1131 | Q8ND23 | |
| GEEDGGSDGMGGDGS | 246 | O94992 | |
| MGPGERAGGGGDAGK | 1 | Q86Y22 | |
| MGEKKEGGGGGDAAA | 11 | Q8IVT5 | |
| GLPAGFDDMEGSGGP | 1021 | P39060 | |
| GEKGEPGDASLGFGM | 1236 | P39060 | |
| GEQGLKGSKGDMGDP | 476 | Q9BXS0 | |
| DMGDPGMTGEKGGIG | 486 | Q9BXS0 | |
| MLEDEAGGGGAGPGG | 41 | Q1KMD3 | |
| MDGNEGPSGGPGGTD | 851 | Q9ULI4 | |
| GEEDMGPGGEDARGG | 616 | Q8N9W4 | |
| MAGLGPGVGDSEGGP | 1 | P05129 | |
| MSGGKSAQGPEEGGV | 1 | Q96FV0 | |
| DGGMAGSKLPGQEGV | 646 | Q7Z3G6 | |
| EQGLREGSGGGGGMD | 71 | O60884 | |
| GPGISAMEASGGDPG | 51 | Q9NVR0 | |
| MGQPKLGTSDGGEGG | 136 | Q8WZ55 | |
| GIDGVDGVKGEMGYP | 326 | P12109 | |
| GEEGGAGEPGKYDSM | 711 | Q14993 | |
| RKEEAGAPGGGAGMA | 186 | P17676 | |
| KGMPSGGGSDEGLAS | 6 | P42772 | |
| GLPGEKGMAGGHGPD | 726 | P05997 | |
| PGEKGETGDVGQMGP | 1236 | P20908 | |
| EGDSGPMGPDGLKGD | 1191 | Q8IZC6 | |
| PDGEHGEKGQEGLMG | 1211 | Q8IZC6 | |
| EPGSKGQPGDSGEMG | 1521 | Q8IZC6 | |
| VGPTGEKGDMGDKGQ | 61 | Q9BWP8 | |
| EGGKDACAGDSGGPM | 636 | P48740 | |
| EGGIGGVPGMEAHGG | 236 | P49356 | |
| MSEPGGGGGEDGSAG | 1 | Q14204 | |
| TGVGDGGNELGMGKV | 476 | Q7Z3D6 | |
| KTGMGSGSAGKEGGP | 316 | Q86YS7 | |
| PGEKGEVGDVGSMGP | 1156 | P25940 | |
| MADGDSGSERGGGGG | 1 | Q96QR8 | |
| GEKGDQGAMGSPGLH | 206 | A6NHN0 | |
| MGEAGAGAGASGGPE | 1 | Q9BTY7 | |
| GGGGDMAEPSEAGDA | 311 | P08621 | |
| GKMGGEEKPIGAGEE | 11 | P26639 | |
| MDELAGGGGGGPGMA | 1 | Q13033 | |
| MAENKGGGEAESGGG | 1 | Q9UPN9 | |
| GNGDPGGGMEKDGPE | 341 | Q9NPC1 | |
| MGEAEVGGGGAAGDK | 1 | Q9NV56 | |
| MEAPSGSEPGGDGAG | 1 | Q8TCU6 | |
| LGGDEDKMENGSGGG | 411 | P47736 | |
| MAAEKQVPGGGGGGG | 1 | Q9UHB9 | |
| DMGRTGGGVGPKGGV | 841 | Q8WZ75 | |
| DGDGEGAGGAPEEMP | 286 | P28702 | |
| GPADAGGAMAAKPGE | 306 | Q7Z7L8 | |
| EMGMEGPPGTEGESG | 1006 | Q17RW2 | |
| KLFTEGGGGAVMGAG | 61 | O15156 | |
| GGMGDKVEERGKEGP | 266 | Q05516 | |
| MLGKGFGDVGEAKGG | 341 | Q14157 | |
| EGDMGAAGGDGELGS | 206 | Q9BQI7 | |
| GGGGPVMVGGDADAR | 56 | Q6NVU6 | |
| DDMKDHGGGCGGPEA | 241 | O94964 | |
| GAGGTSSGDDGEMPA | 466 | Q9BY07 | |
| GAGKMAAAAGQDGGG | 61 | Q6ZSY5 | |
| PGAGAKASGEGMAGD | 1351 | O95359 | |
| MEGGGGSGDKTTGVL | 1 | Q5SRD1 | |
| MPQLDSGGGGAGGGD | 1 | P36402 | |
| MEEKYGGDVLAGPGG | 1 | Q8TAD4 | |
| MAGVGDAAAPGEGGG | 1 | Q6NXT6 | |
| MADDAGAAGGPGGPG | 1 | P15880 | |
| MEAGAGGAGSDTKGG | 1 | A0A1B0GWB2 | |
| MPGAGARAEEGGGGG | 1 | Q9UPU7 | |
| PGGSGGRKMAAGDIG | 11 | Q92995 | |
| SGPSVPGMGGDGEED | 136 | Q9NZM1 |